for variance from Mary Lynn Ulrey, Chief Executive Officer of the Drug Abuse Comprehensive Coordinating Office, seeking a variance of section 64K-1.003(1), F.A.C. Petitioner requests that the Department allow individuals with direct access to the ...

 

DEPARTMENT OF HEALTH

Prescription Drug Monitoring Program

RULE NO.:RULE TITLE:

64K-1.003Accessing Database

NOTICE IS HEREBY GIVEN that on January 26, 2016, the Department of Health, received a petition for variance from Mary Lynn Ulrey, Chief Executive Officer of the Drug Abuse Comprehensive Coordinating Office, seeking a variance of subsection 64K-1.003(1), F.A.C. Petitioner requests that the Department allow individuals with direct access to the Prescription Drug Monitoring Program database to appoint a designee to access on behalf of the prescriber.

Any interested person or other agency may submit written comments within 14 days after the publication of this notice to: Prescription Drug Monitoring Program, Florida Department of Health, 4052 Bald Cypress Way, Bin #C16, Tallahassee, Florida 32399-3299.

A copy of the Petition for Variance or Waiver may be obtained by contacting: Rebecca Poston, Program Manager, Prescription Drug Monitoring Program, 4052 Bald Cypress Way, Bin #C16, Tallahassee, Florida 32399-3299, [e-mail].